FIBRICOR (Page 7 of 7)

———PRINCIPAL DISPLAY PANEL — 35 mg Tablet———

NDC 71511-501 -30 30 TABLETS

FIBRICOR ^®
(fenofibric acid) Tablets

35 mg

Rx Only

ATHENA
BIOSCIENCE

———PRINCIPAL DISPLAY PANEL — 105 mg Tablet———

NDC 71511-502 -30 30 TABLETS

FIBRICOR^®
(fenofibric acid) Tablets

105 mg

Rx Only

ATHENA
BIOSCIENCE

FIBRICOR fenofibric acid tablet

Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:71511-501 Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Fenofibric Acid (Fenofibric Acid) Fenofibric Acid 35 mg

Inactive Ingredients Ingredient Name Strength Copovidone K25-31 crospovidone magnesium stearate cellulose, microcrystalline

Product Characteristics Color WHITE Score no score Shape ROUND Size 9mm Flavor Imprint Code AR;787 Contains

Packaging # Item Code Package Description Multilevel Packaging 1 NDC:71511-501-30 30 TABLET in 1 BOTTLE, PLASTIC None

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA022418 08/05/2017

FIBRICOR fenofibric acid tablet

Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:71511-502 Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Fenofibric Acid (Fenofibric Acid) Fenofibric Acid 105 mg

Inactive Ingredients Ingredient Name Strength Copovidone K25-31 crospovidone magnesium stearate cellulose, microcrystalline

Product Characteristics Color WHITE Score no score Shape OVAL (Modified Oval) Size 19mm Flavor Imprint Code AR;788 Contains

Packaging # Item Code Package Description Multilevel Packaging 1 NDC:71511-502-30 30 TABLET in 1 BOTTLE, PLASTIC None

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA022418 08/05/2017

Labeler — Athena Bioscience, LLC (080710928)

Revised: 12/2021 Athena Bioscience, LLC